ScholarIQanswers from OpenAlex & ORCID
Joachim R. Kalden
ResearcherPublications, citations & collaboration network
Joachim R. Kalden is a researcher indexed in ScholarIQ from OpenAlex & ORCID.
How many works does Joachim R. Kalden have?
ScholarIQindexed works
Joachim R. Kalden has 124 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Joachim R. Kalden have?
ScholarIQcitation count
Joachim R. Kalden has 16,519 citations in the OpenAlex counts ScholarIQ stores.
What is the h-index of Joachim R. Kalden?
ScholarIQh-index
Joachim R. Kalden has an h-index of 49 in OpenAlex.
What is the i10-index of Joachim R. Kalden?
ScholarIQi10-index
Joachim R. Kalden has an i10-index of 88 in OpenAlex.
What is the OpenAlex record for Joachim R. Kalden?
ScholarIQopenalex
The OpenAlex for Joachim R. Kalden is on the source record.
What are the most-cited papers on Joachim R. Kalden?
ScholarIQmost cited works
Infliximab and Methotrexate in the Treatment of Rheumatoid Arthritis
Peter E. Lipsky, Désirée van der Heijde, E. William St. Clair, Daniel E. Fürst, Ferdinand C. Breedveld, Joachim R. Kalden, Josef S Smolen, Michael H. Weisman, Paul Emery, Marc Feldmann, Gregory R. Harriman, Ravinder N. Maini
Infliximab (chimeric anti-tumour necrosis factor α monoclonal antibody) versus placebo in rheumatoid arthritis patients receiving concomitant methotrexate: a randomised phase III trial
Ravinder N. Maini, E. William St. Clair, Ferdinand C. Breedveld, Daniel E. Fürst, Joachim R. Kalden, Michael H. Weisman, Josef S. Smolen, Paul Emery, Gregory R. Harriman, Marc Feldmann, Peter E. Lipsky
The proteasome inhibitor bortezomib depletes plasma cells and protects mice with lupus-like disease from nephritis
Kirsten Neubert, Silke Meister, Katrin Moser, Florian Weisel, Damián Maseda, Kerstin Amann, Carsten Wiethe, Thomas Winkler, Joachim R. Kalden, Rudolf A. Manz, Reinhard Voll